Rapid increase in purchasing teams expected at CPHI North America

Macro-uncertainty and large CDMO acquisitions attributed to have driven a surge in R&D, purchasing and QC/QA attendees at event

15 Apr 24

CPHI North America opens as 65% of US companies forecast growth in excess of 20% in 2022

CPHI is the leading global community for pharmaceutical professionals and America’s only end-to-end pharma event

04 Apr 22

Japan tops CPhI ‘API Quality’ ranking for second year

Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers

11 Mar 22

2022 will see pharma target nutraceutical products to tap into consumer spending on preventative health

2025 forecast: massive growth expected in consumer-friendly dosages using natural ingredients for proactive & pre-emptive health

14 Jan 22

CPhI predictions for 2022: high manufacturing demand to constrain global ingredients, partnering options and available CDMO capacity

Continued stellar growth in pharma sales and innovation bode well for supply side companies and CDMOs

07 Jan 22

Medinfar awarded first ever CPhI Verified Certificate

CPhI Verified certification improves supply chain transparency, providing a legal, regulatory and quality benchmark

29 Nov 21

Global pharma industry gathers at CPhI Worldwide 2021 as surge in partnering expected in 2022

Over 25,000 online and 23,000 in person attendees at the world’s largest pharma trade exhibition

18 Nov 21

China sees huge bounce in pharma rankings ahead of hybrid CPhI & P-MEC China

China is the pharma industry’s biggest gainer in the 2021 CPhI Annual Rankings, with digital matchmaking driving new waves of partnerships

17 Nov 21

Pharma confidence surges as CPhI Worldwide 2021 opens

CPhI Pharma Index reaches record high as pharma confidence in growth rises in all markets

10 Nov 21

Winners of the 2021 CPhI Pharma Awards have now been announced

10 Nov 21

CPhI Worldwide Report: CMOs will account for four of the five top bio manufacturing capacities in 2025

230 Covid-19 supply agreements known, with demand for larger biocapacity remaining constrained as a consequence of the circa 1000 vaccines in development

05 Nov 21

India sees sizable improvement in finished dosage reputation and growth ahead of CPhI India 2021

CPhI & P-MEC India delivers hybrid event as country improves across all key performance metrics in CPhI global survey

27 Oct 21

Short term reshoring the catalyst for longer term manufacturing innovations by 2030

25 Oct 21

CPhI Worldwide Fiera Milano: Uniting The Industry To Network & Source Cost-Effective Solutions

25 Oct 21

CPhI Report predicts record EBITDAs for CDMOs in 2022

Booster vaccines and capacity constraints during a period of record R&D investment are driving up prices for specialized facilities, advanced therapies and biologics

23 Sep 21

CPhI partners with SGS for Company Verification Service

The ‘CPhI Verified’ certificate will provide pharma companies with an internationally accredited pre-qualification service

11 Aug 21

CPhI Awards 2021 Open for Entries in Incredible Year for Pharma Innovation

Held in Milan to Recognize Excellence in Pharma

19 Jul 21

CPhI report predicts ‘supercharged partnering’ in USA Pharma sector over the next 18-months

US CDMOs to see growth in advanced manufacturing with a ‘golden era’ of longer contracts and more favourable terms

24 Jun 21

Pharma accelerating new partnership development at CPhI Discover ahead of returning in-person events

CPhI Worldwide and Pharmapack Europe given the all-clear by host country governments

26 May 21

Experts state contract services sector the big winner of pandemic at CPhI Discover

Near-term capacity constraints for recombinant vector manufacturing, with continuous bioprocessing & process intensification set for rapid growth in next 5-10 years

21 May 21

CPhI Japan celebrates return, as cell & gene therapies and digital innovation highlighted

28 Apr 21

CPhI post-pandemic executive pharma survey: COVID-19 driving manufacturing and CDMOs driving growth

Executives are extremely bullish on pharma’s business outlook for both the short and medium term

22 Apr 21

CPhI post-pandemic executive pharma survey: COVID-19 driving manufacturing and CDMOs driving growth

Executives are extremely bullish on pharma’s business outlook for both the short and medium term

22 Apr 21

CPhI Discover: event overview and highlights

16 Apr 21

CPhI Discover: connecting global pharma & pre-qualifying partners ahead of in person events

Rapidly expanding outsourcing and supply chain will see pharma combine digital and in person approaches to lead generation

01 Apr 21

Two-month long CPhI Japan Connect to meet demand for pharma partnering in Japan

22 Mar 21

CPhI Report forecasts explosion of contract services growth due to surging INDs and 75 FDA approvals by 2025

COVID-19 vaccines only the beginning of mRNA platform’s potential and a multi-modal disease therapy breakthrough (e.g., MS) predicted within next five years

09 Mar 21

CPhI Worldwide Announces New November 2021 Dates

20 Jan 21

CPhI & P-MEC China gives a glimpse of the success returning pharma events will deliver in 2021

The fully launched MAH and priority review pathways from the NMPA (National Medical Products Administration) is stimulating new demand in China for 2021.

20 Jan 21

Vaccine nationalism, CDMO expansion, AMR and dual sourcing predicted in 2021 according to CPhI Report

30 Nov 20

CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma event

Virtual Expo Connect to empower access for international pharma to the world’s largest pharma ingredients market

16 Nov 20

CDMOs benefit from COVID-19 impacts but mega-cap pharma innovation slowing outsourcing according to CPhI Annual Report

CPhI

09 Nov 20

CPhI Worldwide to return in 2021: Milan venue to play host to global pharma as Italy gears up for strong growth

2021 will bring global pharma community back together in person to drive business growth

20 Oct 20

Approvals of COVID-19 biologics will put huge pressure on large-scale bioprocessing networks, according to CPhI Annual Report

Tightening of bio-manufacturing capacity expected to occur after 2024, whilst Europe forecast to equal North America in total capacity

15 Oct 20

CPhI Announces 17th Annual CPhI Pharma Awards Winners

13 Oct 20

Full CPhI & Pharmapack Europe schedule returns in 2021 with live & hybrid events

Informa Markets announces its complete listing of pharma event dates for 2021 at the opening of the first CPhI Festival of Pharma (05 – 16 October 2020) – the largest ever virtual pharma event.

13 Oct 20

CPhI Annual Report 2020 Part 1: 2025 will see cell and gene therapy capacity shortages in the USA and 10+ mAb approvals in China

Continuous bioprocessing growing quickly, but from a low base, with virtually all manufacturers now using at least some single use technologies

13 Oct 20

CPhI Festival of Pharma: event overview and highlights

01 Oct 20

CPhI Pharma Index: Italy and India the only pharma economies to improve score in 2020

Survey findings highlight importance of international partnering ahead of pharma’s first AI-driven matchmaking event

28 Sep 20

CPhI Middle East & Africa to take place in September 2021 under the patronage of Saudi Arabia’s Ministry of Health

23 Sep 20

World’s Largest Virtual Pharma Expo Agenda Unveiled: Former FDA Commissioner Dr. Scott Gottlieb to address industry on sustainable innovation at CPhI Festival of Pharma

03 Sep 20

CPhI South East Asia rescheduled for 2021

CPhI South East Asia – organised by Informa Markets – has been rescheduled to May 18-20, 2021 to give the ASEAN pharma community more time to recover and to mitigate any global disruptions caused by COVID-19.

04 Aug 20

CPhI Japan rescheduled for Spring 2021 with digital solutions to be launched

CPhI Japan – organised by Informa Markets – announces that, following a detailed review with partners and key industry stakeholders and to ensure the health and safety of our community, the event will be postponed until April 14-16, 2021. The event organiser’s move to the new dates will provide more time for the market to adapt and for a positive business environment to return, with greater easing of international travel restrictions likely by Spring 2021.

27 Jul 20

CPhI Festival of Pharma to support and lead global pharma industry forward with new digital experience in 2020

30 Jun 20

CPhI Middle East & Africa cancelled for 2020 but set to debut in Saudi Arabia in 2021

11 Jun 20

CPhI Worldwide 2020 implements new ‘Informa AllSecure Standard’

04 Jun 20

CPhI & P-MEC China to host ‘Virtual Expo Connect’ in June

08 May 20

Rescheduled CPhI South East Asia to now take place in November

04 May 20

CPhI & P-MEC China moves to December date to enable international attendance

20 Apr 20

2020 CPhI Pharma Awards are Open for Entries

17 Apr 20

CPhI announces new pharma events calendar for 2020

Organizers have acted quickly to secure three new dates for events in Japan, Southeast Asia and North America in response to COVID-19. The new calendar will ensure the pharma community continues to have events to source, learn and network.

17 Mar 20

CPhI Japan to be postponed on request of event attendees

CPhI Japan – organised by Informa Markets – announces that the event will be postponed until a new date later in the year after extensive consultation with key stakeholders and consideration of all alternatives. The event, which was due to take place at the Big Sight Exhibition Centre in Tokyo (16-18 March), will be rescheduled due to the increasingly complex travel arrangements many of its attendees are experiencing as a result of COVID-19.

27 Feb 20

CPhI South East Asia rescheduled for July 2020

CPhI South East Asia – organised by Informa Markets – has been rescheduled for the newly confirmed date of 1-3 July, 2020 at the IMPACT in Muang Thong Thani, Thailand. The move from the original March 4-6 date was taken after careful consideration and consultation with local government and authorities, and advice from the World Health Organisation (WHO) in regard to the Novel Coronavirus (COVID-19).

18 Feb 20

CPhI Southeast Asia Report: executives call for track-and-trace schemes in Southeast Asia

Generics exports and harmonization continuing apace, with Thailand forecast strong near-term opportunities

10 Feb 20

CPhI Worldwide announces the winners of the 16th Pharma Awards

CPhI Worldwide, organised by Informa PLC, announce the winners of the prestigious 2019 CPhI Pharma Awards – celebrating the industry’s top innovators, performers and outstanding achievements across 13 categories, spanning the entire industry supply chain. The winners have been recognised for delivering excellence in pharma and were unveiled during an invitation-only ceremony.

06 Nov 19

CPhI Pharmaceutical Machinery Report: Critical time to invest in machinery with changing drugs pipeline

Ahead of P-MEC 2019, the only dedicated pharmaceutical machinery event in Europe this year – co-located with CPhI Worldwide in Frankfurt, 5-7 November – the first ever CPhI Pharmaceutical Machinery Report identifies trends impacting the market. The findings highlight how the changing drugs pipeline and the industry’s drive towards more efficient manufacturing is necessitating new investments in pharma equipment.

26 Sep 19

Drive for generics sees Korea increasingly attractive to international pharma

Already home to more than 40 pharmaceutical multinationals, Korea is on course to become a global biotech and pharmaceutical hub by 2025, driven by the surge of international partnerships, biosimilars, an expansion in the export of finished formulations and a robust generics market.

01 Aug 19

Huge CPhI & P-MEC China a direct result of surging manufacturing

China’s pharma market continues to expand at a relentless pace, with CPhI & P-MEC China mirroring this trend as it received over 66,000 visits in its 19th edition from some 141 countries. Such was the demand, the event had to add an extra exhibition hall to keep pace with demand for access to the market.

25 Jul 19

CPhI Worldwide opens entries for the CPhI Pharma Awards 2019

CPhI Worldwide, organized by Informa Markets is pleased to announce that the CPhI Pharma Awards, powered by Informa Pharma intelligence will be held on Tuesday, November 5, 2019 in Frankfurt, Germany. The ceremony for this year’s awards, which celebrate innovation in the pharma and biotech industries, will take place on the first evening of the world’s largest pharmaceutical exhibition, CPhI Worldwide.

20 Jun 19

CPhI Japan sees Japanese R&D reinvigorated with international partnerships proliferating

CPhI Japan closes as a new wave of innovation is rising across the country, driven by structural and regulatory changes. A focus on removing long-list products, and the increased use of generics has seen capital re-directed into R&D.

25 Mar 19